| Literature DB >> 34263136 |
Avadhesh Oli1, Divya Balakrishnan2.
Abstract
AIM: To study the long-term outcomes of optic disc pit maculopathy.Entities:
Keywords: optic disc pit; pit maculopathy; schisis; treatment outcomes; vitrectomy
Year: 2021 PMID: 34263136 PMCID: PMC8252332 DOI: 10.1177/25158414211027715
Source DB: PubMed Journal: Ther Adv Ophthalmol ISSN: 2515-8414
Demographic details.
| Variable | Value |
|
|---|---|---|
| Total patients | 50 | |
| Age | Mean (SD) | 29.66 years (13.20) |
| Follow-up | Mean (Months) | 27.16 months |
| Sex | Male | 39 (78%) |
| Female | 11 (22%) | |
| Laterality | RE | 27 (54 %) |
| LE | 23 (46%) | |
| Symptoms | Reduced vision | 46 (92%) |
| Metamorphopsia | 3 (6%) | |
| Scotoma | 1 (2%) | |
| Referral diagnosis | Optic disc pit | 30 (60%) |
| Glaucoma | 6 (12%) | |
| CSCR | 6 (12%) | |
| Others | 8 (16%) | |
| Duration of symptoms | Mean(SD) months | 10.31 (19.54) |
| Follow-up | Mean | 27.18 (29.81) months |
| Clinical findings | Optic disc pit location | |
| Temporal | 35 (70%) | |
| Inferotemporal | 14 (28%) | |
| Inferior | 1 (2%) | |
| Baseline OCT ( | NSD | 13 (39.4%) |
| SRF | 25 (75.8%) | |
| Communication to pit | 7 (21.2%) | |
| Inner retinal schisis | 18 (35.3%) | |
| Outer retinal schisis | 24 (72.7%) | |
| Outer retinal hole | 14 (41.4%) | |
| Treatment | Observation | 10 (20%) |
| Laser | 20 (40%) | |
| PPV | 20 (40%) | |
| Surgical parameters | Gauge of PPV | |
| 20 G | 7 (35%) | |
| 23 G | 7 (35%) | |
| 25G | 6 (30%) | |
| Use of triamcinolone for PVD | 14 (70%) | |
| Juxtapapillary endolaser | 10 (50%) | |
| ILM peel | 9 (45%) | |
| Endotamponade | ||
| C3F8 | 17 (85%) | |
| SF6 | 3 (15%) | |
| Final OCT ( | NSD | 1 (3.2%) |
| SRF | 4 (12.9%) | |
| Communication to pit | 3 (6%) | |
| Inner retinal schisis | 11 (33.33%) | |
| Outer retinal schisis | 6 (18.8%) | |
| Outer retinal hole | 3 (7.9%) |
CSCR, central serous chorioretinopathy; ILM, internal limiting membrane; OCT, optical coherence tomography; PPV, pars plana vitrectomy; PVD, posterior vitreous detachment; SD, standard deviation; SRF, subretinal fluid.
Anatomical and functional outcomes in three groups.
| Observation ( | Laser ( | PPV ( | Remarks | ||
|---|---|---|---|---|---|
| Baseline BCVA | Mean (95% CI) | 0.94 (0.63–1.25) | 0.77 (0.57–0.96) | 0.92 (0.7–1.14) | |
| Final BCVA | Mean (95% CI) | 1.0 (0.75–1.24) | 0.645 (0.45–0.83) | 0.50 (0.33–0.67) | |
| Functional recovery (>2 line improved) | Yes | 1 (10%) | 10 (50%) | 14 (70%) | |
| No | 9 (90%) | 10 (50%) | 6 (30%) | ||
| Anatomical recovery (OCT based) | Yes | 1 (25%) | 5 (38.5%) | 1 (6.3%) | |
| Partial | 0 | 0 | 15 (93.8%) | ||
| No | 3 (75%) | 8 (61.5%) | 0 | ||
| BCVA better than logMAR 0.8 | Yes | 4 (40%) | 14 (70%) | 18 (90%) | |
| No | 6 (60%) | 6 (30%) | 2 (10%) |
ANOVA, analysis of variance; BCVA, best-corrected visual acuity; CI, confidence interval; OCT, optical coherence tomography; PPV, pars plana vitrectomy.
Figure 1.Kaplan Meier survival curve showing the duration of subretinal fluid resolution in months.